Calithera Biosciences, Inc. (OTCPK: CALA)
Health Care · Biotechnology · US
$—
— today · — 1Y
Calithera Biosciences, Inc. (OTCPK: CALA) operates in the Biotechnology industry within the Health Care sector. The company is valued at $487.00 and employs 8 people.
trading between 0.00 and 0.00.
Tweenvest scores Calithera Biosciences, Inc. across four factors: quality 36/100. Its strongest factor is quality.
CALA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $487.00
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -7.94
- Dividend yield
- —
- Beta (5Y)
- -1.21
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 4.87M
- Employees
- 8
- Next earnings
- —
About Calithera Biosciences, Inc.
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.
- ISIN
- US13089P5070
- Founded
- 2010
- Listed since
- Oct 2, 2014
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $464.58B | $262.90 | -1.09% |
| Amgen Inc.NasdaqGS: AMGN | $238.06B | $440.34 | -0.43% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $183.64B | $148.09 | -0.01% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.72B | $547.29 | -1.01% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $81.36B | $814.79 | -2.25% |
| argenx SEENXTBR: ARGX | $65.40B | €897.60 | +2.09% |
| Moderna, Inc.NasdaqGS: MRNA | $59.75B | $149.66 | -5.77% |
| CSL LimitedASX: CSL | $59.19B | AU$172.44 | -0.69% |
Figures last refreshed Aug 18, 2026.